FDA establishment 3014779728, India. Part of Glenmark Pharmaceuticals's FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations, and the shipments FDA refused at the border.
FDA has posted no inspections for this site.
| Product | Charges | Latest |
|---|---|---|
| CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)Drugs · 61WCY04 | Oct 23, 2026 | |
| LINEZOLID (OXAZOLIDINONE)Drugs · 56PCB01 | Aug 31, 2026 | |
| NAPROXEN SODIUM (ANTI-INFLAMMATORY)Drugs · 62GDA50 | Aug 25, 2026 | |
| ALBUTEROL (BRONCHODILATOR)Drugs · 63BDY01 | Jul 30, 2026 | |
| OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL)Drugs · 62KDE10 | Jul 24, 2026 | |
| MINOXIDIL (ANTI-HYPERTENSIVE)Drugs · 62CDL41 | Mar 21, 2024 |
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. FDA Data Dashboard and warning letters
India. Part of